Key result
This review discusses the diagnostic and therapeutic aspects of hibernating myocardium, noting that recognition is difficult and treatment protocols are poorly defined.
This review outlines the diagnostic and therapeutic challenges of hibernating myocardium, including the potential role of neurohormonal antagonists.
Answers are grounded in this paper and cite their sources.
Difficult recognition and undefined treatment protocols for hibernating myocardium persist; leaves open the need for standardized approaches and prospective trials.
Hibernating myocardium is characterized by chronic reduction of myocardial blood flow due to obstructive coronary artery disease, causing reversible left ventricular dysfunction and flow-metabolism mismatch. The condition is unstable and increasing demand may lead to further left ventricular dysfunction or necrosis causing death or worsening heart failure. Recognition of the condition is difficult and requires complex cardiac imaging protocols. Treatment protocols are also poorly defined. This review addresses both the diagnostic and therapeutic aspects of hibernating myocardium.
No takes yet. Share an insight, caveat, or question.
Lahiri et al. (1999) conducted a review in Hibernating myocardium. Neurohormonal Antagonists was evaluated. This review discusses the diagnostic and therapeutic aspects of hibernating myocardium, noting that recognition is difficult and treatment protocols are poorly defined.
Synapse has enriched 10 related papers. Consider them for comparative context: